In a small randomized controlled clinical trial, a single immunization for malaria using mosquitoes infected with attenuated parasites showed unprecedented 90% protective efficacy and did not lead to breakthrough disease.
- Geert V. T. Roozen
- Roos van Schuijlenburg
- Meta Roestenberg
